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Gene organization and evolutionary history
Transient receptor potential (TRP) genes were first des­
cribed in the fruit fly Drosophila melanogaster. Studies in 
its visual system identified a visually impaired mutant fly 
that had a transient response to steady light instead of the 
sustained electro­retinogram recorded in the wild type 
[1]. This mutant was therefore called transient receptor 
potential; however, it took about two decades before the 
trp gene was identified by Montell and Rubin in 1989 [2]. 
From its structural resemblance to other cation channels 
and detailed analysis of the permeation properties of the 
light­induced current in the trp mutant, the product of 
the trp gene was proposed to be a six­transmembrane­
segment  protein  that  functions  as  a  Ca2+­permeable 
cation channel [3]. Currently, more than 100 TRP genes 
have been identified in various animals (Table 1). Human 
TRP genes are diverse in length and range between 11.4 
and about 911 kb, with the number of exons varying from 
11 to 39. The overall protein sequence homology between 
subfamily members in the same species is usually about 
35%, but for clear duplication pairs (such as TRPC6 and 
TRPC7, TRPM4 and TRPM5, and TRPV5 and TRPV6) 
this may reach 50 to 80%. Regulatory elements in pro­
moters of TRP genes have not been identified.
From protein homology, members of the TRP channel 
family can be seen to fall into seven subfamilies [4]. The 
number of channels within each subfamily varies across 
species (Figure 1 and Table 1). The transmembrane seg­
ments  tend  to  share  the  greatest  homology  within  a 
particular  subfamily.  The  TRPC  subfamily  (‘canonical’) 
comprises closest homologs of Drosophila trp channels. 
TRPVs (‘vanilloid’) are named after a founding member 
vanilloid receptor 1 (now TRPV1). The TRPM subfamily 
groups homologs of melastatin­1 (now TRPM1). TRPMLs 
and  TRPPs  include  mucolipins  and  polycystins,  respec­
tively. All members of the TRPA subfamily are nocicep  tive 
channels  characterized  by  the  presence  of  about  14 
ankyrin repeats. The TRPN subfamily is named after the 
‘NO­mechano­potential C’ (NOMP­C) channel of Caenor­
habditis elegans. So far, the only TRPN family member to 
be identified in vertebrates is from zebrafish [5].
Within  the  six  kingdoms  of  life,  bacteria,  protozoa, 
chromista, plantae, fungi and animalia [6], TRP­related 
Summary
The transient receptor potential (TRP) multigene 
superfamily encodes integral membrane proteins 
that function as ion channels. Members of this family 
are conserved in yeast, invertebrates and vertebrates. 
The TRP family is subdivided into seven subfamilies: 
TRPC (canonical), TRPV (vanilloid), TRPM (melastatin), 
TRPP (polycystin), TRPML (mucolipin), TRPA (ankyrin) 
and TRPN (NOMPC-like); the latter is found only in 
invertebrates and fish. TRP ion channels are widely 
expressed in many different tissues and cell types, 
where they are involved in diverse physiological 
processes, such as sensation of different stimuli or 
ion homeostasis. Most TRPs are non-selective cation 
channels, only few are highly Ca2+ selective, some are 
even permeable for highly hydrated Mg2+ ions. This 
channel family shows a variety of gating mechanisms, 
with modes of activation ranging from ligand binding, 
voltage and changes in temperature to covalent 
modifications of nucleophilic residues. Activated 
TRP channels cause depolarization of the cellular 
membrane, which in turn activates voltage-dependent 
ion channels, resulting in a change of intracellular 
Ca2+ concentration; they serve as gatekeepers for 
transcellular transport of several cations (such as 
Ca2+ and Mg2+), and are required for the function 
of intracellular organelles (such as endosomes and 
lysosomes). Because of their function as intracellular 
Ca2+ release channels, they have an important 
regulatory role in cellular organelles. Mutations in 
several TRP genes have been implicated in diverse 
pathological states, including neurodegenerative 
disorders, skeletal dysplasia, kidney disorders and pain, 
and ongoing research may help find new therapies for 
treatments of related diseases.
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© 2011 BioMed Central LtdTable 1. The TRP channel familya
	 Drosophila	 Caenorhabditis	 Ciona	 Fugu	 Danio	 Mus	 Homo
	 melanogaster	 elegansb	 intestinalisb	 rubripes	 reriob	 musculus	 sapiens
TRPC  3  3  8  8  8  7  6
TRPV  3  5  2  4  4  6  6
TRPM  1  4  2  6  6  8  8
TRPA  4  2  4  1  2  1  1
TRPN  1  1  1  -  1  -  -
TRPML  4  1  9  2  2  3  3
TRPP  1  1  1  4  4  3  3
Total  17  17  27  25  27  28  27
aTRP channels in the fruit fly Drosophila melanogaster, the worm Caenorhabditis elegans, the sea squirt Ciona intestinalis, the puffer fish (Seifuku, Fugu rubripes), the 
zebrafish (Danio rerio), mouse and human. The numbers correspond to proteins with distinct channel properties within each subfamily [104-106]. For more detailed 
information concerning properties of TRP channels, please refer to the IUPHAR database [103]. bOthers report about 60 TRPs in zebrafish, 30 in sea squirts and 24 in 
C. elegans.
Figure	1.	A	phylogenetic	tree	of	human	TRP	channels. Sequence homology analyses show that all TRP channels fall into seven subfamilies that 
comprise proteins with distinct channel properties. Because TRPC2 is a pseudogene in human and TRPNs are not present in mammals, we used 
mouse TRPC2 (ENSMUSP00000102562) and fish TRPN1 (ENSDARP00000093955) to show relations between all subfamilies. Protein sequences were 
aligned using ClustalW2 at the EMBL-EBI server. Phylogenetic distances were calculated using PAM matrix and the unrooted tree was obtained 
using NJplot [102]. The TRP subfamilies are represented by different colors. The scale bar represents 0.2 substitutions. Ensembl protein IDs for 
human protein sequences used in the analysis are as follows: TRPM1, ENSP00000380897; TRPM2, ENSP00000381023; TRPM3, ENSP00000350140; 
TRPM4, ENSP00000252826; TRPM5, ENSP00000387965; TRPM6, ENSP00000354006; TRPM7, ENSP00000320239; TRPM8, ENSP00000323926; 
TRPV1, ENSP00000174621; TRPV2, ENSP00000342222; TRPV3, ENSP00000301365; TRPV4, ENSP00000261740; TRPV5, ENSP00000265310; TRPV6, 
ENSP00000352358; TRPC1, ENSP00000273482; TRPC3, ENSP00000368966; TRPC4, ENSP00000369003; TRPC5, ENSP00000262839; TRPC6, 
ENSP00000340913; TRPC7, ENSP00000426070; TRPML1, ENSP00000264079; TRPML2, ENSP00000359640; TRPML3, ENSP00000304843; TRPP2, 
ENSP00000237596; TRPP3, ENSP00000325296; TRPP5, ENSP00000290431; TRPA1, ENSP00000262209.
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Page 2 of 11genes seem to be found only in fungi and animalia. Des­
pite extensive genomic studies, no single TRP­encoding 
gene  has  been  identified  in  land  plants  so  far,  but  the 
genome  of  chlorophyte  algae  seems  to  contain  several 
types of putative TRP­like genes [7]. In the green alga 
Ostreo  coccus  tauri,  at  least  one  of  the  putative  genes 
might encode a potential TRP channel involved in a Ca2+ 
signaling pathway. Therefore, land plants might have lost 
TRP channels after their divergence from the chlorophyte 
algae [7].
In  fungi,  the  TRP  family  is  represented  by  a  single 
member, TrpY1 (also known as Yvc1 for yeast vacuolar 
conductance  1),  which  encodes  a  vacuolar  membrane 
protein that functions as a mechano­sensor of vacuolar 
osmotic pressure in yeast [8­11]. The yeast TRP channel 
is activated in a Ca2+­dependent manner through stretch­
ing of the vacuolar membrane [12,13] as well as by indole 
and other aromatic compounds [8,9]. The action of aro­
matic ligands requires the presence of aromatic residues 
in  the  sixth  transmembrane  segment  that  might  be 
counter  parts of those found in several TRP channels of 
multicellular  organisms  [8,9].  Because  TrpY1p  shares 
only partial homology with other known TRPs, it might 
be  considered  as  one  of  the  ancient  mechano­  and 
chemosensors [14,15].
Choanoflagellates are unicellular and colonial organisms 
considered to be the common ancestor of animals. It has 
been  hypothesized  that  these  colony­forming  flagellate 
eukaryotes  developed  a  Ca2+  signaling  system  that 
comprises homologs of various types of animal plasma 
membrane  Ca2+  channels,  including  the  store­operated 
channel,  ligand­operated  channels,  voltage­operated 
channels, second messenger­operated channels, and five 
out of six animal TRP channel families [16]. Thus, it is 
very  likely  that  these  choanoflagellate  genes  served  as 
ancestors for the evolution of different TRP subfamilies 
in  animals;  further  expansions  within  subfamilies  may 
have  mainly  occurred  by  gene  duplications  (Figure  1). 
During  evolution,  most  vertebrates  lost  the  mechano­
sensitive TRPN channels but almost doubled the number 
of  TRPs  involved  in  calcium  and  magnesium  homeo­
stasis, thermo­ and chemosensing and calcium signaling 
(TRPCs, TRPVs and TRPMs; Table 1).
Characteristic structural features
Owing to the shortage of accurate X­ray crystallography 
data  describing  the  three­dimensional  structure  of  an 
entire TRP channel, most information concerning TRP 
domain composition comes from in silico and structure/
function  relationship  studies.  It  is  thought  that  most 
TRPs  function  as  homotetramers.  The  formation  of 
heteromultimeric  channels  between  members  of  the 
same  subfamily  or  different  subfamilies  has  been  des­
cribed in several cases (such as between the TRPCs), and 
this could potentially create a wide variety of channels; 
however, it is debatable whether or not these multimeric 
channels are formed [17]. A typical TRP protein contains 
six putative transmembrane segments (S1 to S6) with a 
pore­forming reentrant loop between S5 and S6 [18,19] 
(Figure 2). Intracellular amino and carboxyl termini are 
variable in length and consist of a variety of domains [18]. 
From cryo­electron microscopy data on TRPC3, the large 
intracellular  domain  can  be  seen  as  a  ‘nested  box’ 
structure: a ‘wire frame’ outer shell acts as a sensor for 
activators and modulators, and a globular inner chamber 
might modulate ion flow [20]. Interestingly, in a few cases 
the carboxy­terminal tails contain entire enzyme activi­
ties. For example, a Nudix hydrolase domain of TRPM2 
functions  as  an  ADP­ribose  pyrophosphatase  [21].  In 
TRPM6  and  TRPM7  an  atypical  α­kinase  domain  is 
involved in regulation of channel function [22,23]. Another 
feature  in  the  amino  termini  of  many  TRPs  is  the 
presence of ankyrin repeats, 33­residue motifs consisting 
of pairs of antiparallel α­helices connected by β­hairpin 
motifs.  The  number  of  repeats  in  the  ankyrin  repeat 
domain (ARD) can vary between different TRPs: 3 to 4 in 
TRPCs, 6 in TRPVs, 14 to 15 in TRPAs and about 29 in 
TRPNs. Functionally, ARD seems to be connected with 
tetramerization  of  the  channel  and  interactions  with 
ligands and protein partners [24]. Currently, the ARD of 
TRPV channels is the only domain out of the entire TRP 
superfamily  for  which  high  resolution  crystallographic 
data have so far been obtained [25,26].
The presence of other domains and motifs that influ­
ence channel functions, such as coiled coils, calmodulin­
binding  sites,  lipid­interaction  domains,  EF  hands  or 
phosphorylation sites, is highly variable and very often 
not preserved in all members within the same subfamily 
(for more details see [18]).
Localization and function
TRPs  are  expressed  in  almost  every  cell  type  in  both 
excitable and non­excitable tissues (Table 2). TRP channels 
are present in all cellular membranes, with the exception 
of  the  nuclear  envelope  and  mitochondria.  Most  TRP 
channels are localized in the plasma membrane, where 
they  have  an  essential  role  in  the  influx  and/or  trans­
cellular machinery that transports Ca2+, Mg2+ and trace 
metal ions, and they modulate the driving force for ion 
entry. These contributions are essential for several physio­
logical processes, ranging from pure sensory functions 
(such as pheromone signaling, taste transduc  tion, noci­
cep  tion  and  temperature  sensation)  and  homeo  static 
functions (such as Ca2+ and Mg2+ reabsorption and osmo­
regulation)  to  many  other  motile  functions,  such  as 
muscle contraction and vasomotor control.
The functions of TRP channels at specific locations are 
often  modulated  by  their  associations  with  accessory 
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Page 3 of 11proteins (such as TRPV4 and PACSIN3, a protein kinase 
C  and  casein  kinase  II  substrate  in  neurons  that  is 
involved in synaptic vesicular membrane trafficking and 
regulation of dynamin­mediated endocytotic processes) 
and  by  formation  of  signaling  complexes  with  various 
signaling proteins (such as TRPM4 and phospholipase C 
Figure	2.	Predicted	structural	topology	of	TRP	channels. (a) All channels contain six transmembrane segments (S1 to S6) with a putative pore 
region (P) between S5 and S6. Amino and carboxyl termini are variable in length and contain different sets of domains. (b) Distribution of domains 
in selected human TRP channels [103]. The number and composition of domains vary between different TRP channels and are only partially 
preserved within members of the same subfamily. aa, amino acids; CaM, calmodulin; EF hand, helix-loop-helix Ca2+ binding motif; PH, pleckstrin 
homology domain; ER, endoplasmic reticulum; NUDIX domain, nucleoside diphosphate linked moiety X-type motif.
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Page 4 of 11Table 2. Expression and function of human and mouse TRP channels
Channel	subunit Chromosomal	location Cellular	expression Physiological	functions
TRPC subfamily
    TRPC1 Human: 3q22-q24; 
mouse: 9 E4
Ubiquitous Generation of the excitatory postsynaptic potential in brain; 
netrin-1 and brain-derived neurotrophic factor (BDNF)-mediated 
growth cone guidance; connections to sleep/wakefulness states, 
alertness and appetite; brain development (together with TRPC5); 
glutamate signaling in hippocampus; regulation of smooth muscle 
contraction pulmonary system; platelet function; skeletal muscle 
differentiation; mechano-sensation?
    TRPC2 Human: 11p15.4-p15.3 
(pseudogene);  
mouse: 7 F1
Dendritic tips of the vomeronasal 
sensory neurons and spermatozoa 
(mouse)
Pheromone detection that regulates sexual and social behaviors, 
such as gender recognition and male-male aggression (mouse)
    TRPC3 Human: 4q25-q27; 
mouse: 3 B
Central nervous system (CNS) and 
smooth and cardiac muscle cells
BDNF-mediated growth cone guidance (TRPC1-independent); 
spine formation in brain; γ-aminobutyric acid signaling in striatum; 
astrocyte function; moto-control in cerebellum; cerebral vaso-
motor control; erythropoietin function; functional coupling to 
orexin receptor
    TRPC4 Human: 13q13.1-q13.2; 
mouse: 3 D
Placenta, adrenal gland, CNS, 
endothelium, smooth muscle cells, 
kidney, intestinal cells of Cajal
Endothelium-dependent vasorelaxation and regulation of 
transcellular permeation of the endothelial layer; cell-cell adhesion 
in endothelium through junctional proteins; hypoxia sensing 
together with TRPC1 
    TRPC5 Human: Xq23-q24; 
mouse: X F2
Brain, especially in fetal brain and very 
weak expression in other tissues
Brain development (together with TRPC1); neurite growth, 
growth cone guidance and morphology; anxiety, fear and reward 
processing in nucleus accumbens
    TRPC6 Human: 11q21-q22; 
mouse: 9 A1
Smooth muscle cells, lung, brain, 
placenta, kidney (podocyte foot 
processes), spleen, ovary and small 
intestine, neutrophils
Vaso-motor regulation; α1 signaling in smooth muscle; smooth 
muscle proliferation; angiogenesis; endocannabinoid signaling 
in the brain; promotion of dendrite growth and synapse forming 
in the developing brain; glomerular filter integrity in the kidney; 
platelet function; redox sensor; mechano-sensor?
    TRPC7 Human: 5q31.2;  
mouse: 13 B2
Pituitary glands, kidney and CNS 
(human); heart and lung; weak in CNS 
and kidney (mouse)
Controls respiratory rhythm activity in pre-Bötzinger complex in 
the brain 
TRPV subfamily
    TRPV1 Human: 17p13.3;  
mouse: 11 B3
Dorsal root and trigeminal ganglia; 
spinal and peripheral nerve terminals, 
brain, skin (cutaneous sensory 
nerve fibers, mast cells, epidermal 
keratinocytes, dermal blood vessels, the 
inner root sheet and the infundibulum 
of hair follicles, differentiated sebocytes, 
sweat gland ducts, and the secretory 
portion of eccrine sweat glands), 
pancreas, bladder (urothelium, smooth 
muscle, blood vessels and neurons)
Thermo-sensation (heat); autonomic thermoregulation; 
nociception; pain management; synaptic plasticity in the brain 
(long-term depression); endocannabinoid signaling in the brain; 
food intake regulation; growth cone guidance in the brain; 
osmosensing in the brain by a particular TRPV1 variant; multiple 
functions in the gut
    TRPV2 Human: 17p11.2;  
mouse: 11 B2
Dorsal root ganglia and CNS neurons, 
gastro-intestinal tract, spleen, mast cells, 
smooth, cardiac and skeletal muscle 
cells 
Thermo-sensation (noxious heat); nociception; axon outgrowth in 
spinal motor neurons; critical for phagocytosis in macrophages
    TRPV3 Human: 17p13.3;  
mouse: 11 B4
Dorsal root and trigeminal ganglion 
neurons, brain, keratinocytes, hair 
follicles, tongue and testis
Thermo-sensation (moderate heat); nociception; skin integrity, 
wound healing, hair growth and sebocyte function
    TRPV4 Human: 12q24.1;  
mouse: 5 F
CNS (large neurons), trigeminal ganglia, 
heart, liver, kidney, skin (keratinocytes), 
osteoblasts, blood vessels 
(endothelium), bladder (urothelium) 
and testis, cochlea (inner and outer hair 
cells, marginal cells of the cochlear stria 
vascularis), kidney (epithelial cells of 
tubules and glomeruli)
Thermo-sensation (moderate heat); mechano-sensation; 
osmo-sensation; nociception; modulation of cell migration; 
endothelium vaso-motor control and possible shear stress sensor; 
mechano-receptor in urothelium (important for voiding control); 
osteogenesis and osteoclast function; important in human bone 
and neurodegenerative diseases; control adherens junctions in 
skin; cochlea
    TRPV5 Human: 7q35;  
mouse: 6 B2
High in kidney; lower in gastro-intestinal 
tract, pancreas, testis, prostate, placenta, 
brain and salivary gland
Ca2+ (re)absorption channel in kidney and intestines
Continued overleaf
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Page 5 of 11(PLC)  isoforms  and  phosphatidylinositol  kinases/phos­
phatases)  [27,28].  Currently,  the  mechanisms  of  intra­
cellular trafficking of TRP channels and their guidance to 
the  plasma  membrane  or  to  intracellular  locations  are 
mostly unknown [29].
TRPs	and	disease
Several  TRP  genes  are  implicated  in  a  wide  range  of 
diseases in humans [30,31]. These fall under the umbrella 
of  the  ‘channelopathies’,  which  are  defined  as  diseases 
caused  by  impaired  channel  functions,  resulting  from 
Table 2. Continued
Channel	subunit Chromosomal	location Cellular	expression Physiological	functions
    TRPV6 Human: 7q33-q34; 
mouse: 6 B2
High in gastro-intestinal tract; lower 
in kidney, pancreas, testis, prostate, 
placenta, brain and salivary gland
Ca2+ (re)absorption channel in intestines and kidney; key player in 
Ca2+/1,25-dihydroxyvitamin D3-induced keratinocyte development 
in the skin
TRPM subfamily
    TRPM1 Human: 15q13-q14; 
mouse: 7 C
Skin melanocytes, retinal bipolar ganglia Light response in ON bipolar retinal ganglia cells; tumor repressor 
in melanoma cells 
    TRPM2 Human: 21q22.3; mouse: 
10 C1
Brain, bone marrow, peripheral blood 
cells (neutrophils), lung, spleen, eye, 
heart and liver
Oxidative and nitrosative stress response; activation of 
granulocytes; pancreas insulin release; critical in apoptosis 
    TRPM3 Human: 9q21.13; mouse: 
19 C1
Primarily in kidney; lower in brain, 
sensory neurons, testis, ovary, pancreas 
and spinal cord
Steroid hormone (pregnanolon) sensor; possible regulator in 
endocrine pancreas, glia cells and cerebellar Purkinje cells 
    TRPM4 Human: 19q13.32; mouse: 
7 B4
Heart, exo- and endocrine pancreas, 
mast cells, smooth muscle, macula 
densa, lung and placenta 
Mast cell degranulation (histamine release) and migration as a 
critical Ca-impermeable cation channel regulating Ca2+ entry; 
catecholamine release from chromaffin cells; vasopressin release 
from paraventricular and supraoptic hypothalamic nuclei
    TRPM5 Human: 11p15.5; mouse: 
7 F5
Tongue (taste bud cells), lungs, testis, 
digestive system, brain, endocrine 
pancreas
Taste (sweet, bitter, umami); positive regulator of glucose-induced 
insulin release; trigeminal nasal chemoreception
    TRPM6 Human: 9q21.13; mouse: 
19 B
Kidney, colon and intestine Mg2+ homeostasis and reabsorption in kidney and intestine
    TRPM7 Human: 15q21; mouse: 
2 F2
Ubiquitous Mg2+ homeostasis and reabsorption in kidney and intestine; 
cell cycle control; gastrulation; development of thymocytes 
(thymopoiesis); cell migration; shear stress sensor?; skeletogenesis? 
    TRPM8 Human: 2q37.1; mouse: 
1 C5
Sensory dorsal root and trigeminal 
ganglia neurons, nodose ganglion cells 
innervating the upper gut, vascular 
smooth muscle cells, liver, gastric 
fundus, bladder (urothelium) and 
different tissues of the male genital tract; 
high in tumors from prostate, breast, 
colon, lung and skin 
Thermo-sensation (cold); sperm motility, acrosome reaction 
TRPA1 subfamily
    TRPA1 Human: 8q13; mouse: 
1 A3
Hair cells, sensory dorsal root and 
trigeminal ganglia neurons, fibroblasts
Thermo-sensation (noxious cold); the most versatile chemo-sensor; 
mechano-sensation?; nociception; olfactory responses; cold-
induced contraction in colon and bladder 
TRPML subfamily
    TRPML1 Human: 19p13.3-13.2; 
mouse: 8 A1.1
Ubiquitous; intracellular ion channel Essential for endocytosis and endosomal/lysosomal function; 
regulation of autophagy
    TRPML2 Human: 1p22; mouse: 
3 H3
Ubiquitous; intracellular ion channel Endosomal/lysosomal function
    TRPML3 Human: 1p22.3; mouse: 
3 H3
Hair cells (stria vascularis, stereocilia); 
intracellular ion channel
Endosomal/lysosomal function; autophagy; hair cell maturation?
TRPP subfamily
    TRPP2 Human: 4q22; mouse: 
5 E4
Ubiquitous; mostly in ovary, fetal and 
adult kidney, testis, and small intestine 
in both motile and primary cilia
Cardiac, skeletal and renal development; integrity of the vessel 
wall; negative regulator of endogenous mechano-sensitive 
channels; mechano-receptor and flow-sensor in endothelium; 
apoptosis 
    TRPP3 Human: 10q24-q25; 
mouse: 19 D1
Adult heart, skeletal muscle, brain, 
spleen, testis, retina and liver
Renal development; part of putative sour sensor 
    TRPP5 Human: 5q31; mouse: 
18 B3
Testis, brain and kidney Spermatogenesis?
BDNF, brain-derived neurotrophic factor; CNS, central nervous system.
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mechanism, such as autoimmunity.
TRPC6
Mutations in TRPC6 are linked to the human proteinuric 
kidney  disease  called  focal  and  segmental  glomerulo­
sclerosis  (FSGS).  FSGS  patients  show  defects  in  the 
permeability barrier function in glomeruli, resulting in 
proteinuria and progressive kidney failure [32­34].
TRPV4
Mutations in TRPV4 are linked with inherited disorders 
of  bone  growth,  including  brachyolmias  and  skeletal 
dysplasias mainly characterized by short trunk, scoliosis 
and mild short stature [35].
TRPV4 has also been implicated in neurodegenerative 
disorders, such as scapuloperoneal spinal muscular atrophy 
(SPSMA)  and  Charcot­Marie­Tooth  disease  type  2C 
(CMT2C, known also as hereditary motor and sensory 
neuropathy  type  2C)  [36­39].  SPSMA  is  described  by 
progressive  weakness  of  scapular  and  peroneal  muscle 
tissue,  bone  abnormalities  and  laryngeal  palsy  (the 
paralysis often being accompanied by loss of sensation). 
CMT2C results in progressive weakness of distal limbs, 
vocal  cords,  diaphragm,  and  intercostal  and  laryngeal 
muscles;  impaired  hearing  and  vision;  some  bone 
abnormalities, such as scoliosis; and bladder urgency and 
incontinence [36,37,39].
TRPM1
Melastatin or TRPM1 has been identified as a putative 
tumor suppressor in melanoma cells [40­42]. Mutations 
in TRPM1 are linked to autosomal­recessive congenital 
stationary  night  blindness  (CSNB).  CSNB  is  a  hetero­
gene  ous group of retinal disorders characterized by non­
progressive impaired night vision and variable decreased 
visual acuity as a consequence of the loss of function of 
rod and cone ON bipolar cells in the retina [43­47].
TRPM4
Mutations resulting in Asn7Lys substitution in the amino­
terminal part of the TRPM4 channel cause autosomal­
dominant  progressive  familial  heart  block  type  1 
(PFHB1), a cardiac bundle branch disorder that affects 
the electrical conduction of the heart and may progress 
to  a  complete  heart  block.  Increased  TRPM4  mutant 
channel density in the plasma membrane, resulting from 
impaired  endocytosis,  very  likely  depolarizes  the 
conduction system and causes the heart block [48].
TRPM6
The  TRPM6  locus  is  associated  with  hypomagnesemia 
with  secondary  hypocalcemia  (HSH/HOMG),  an  auto­
somal recessive disorder characterized by low Mg2+ and 
Ca2+ levels in serum, resulting from impaired intestinal 
Mg2+ absorption and renal Mg2+ leak [49,50]. TRPM6 has 
a crucial role in active transcellular Mg2+ uptake at the 
apical  membrane  of  the  brush­border  epithelium  in 
intes  tines.  Magnesium  overload  is  also  prevented  by 
TRPM6,  which  is  tightly  regulated  by  the  intracellular 
Mg2+ concentration [51].
TRPA1
The  nociceptive  TRPA1  channel  is  implicated  in  the 
etiology of an autosomal dominant familial episodic pain 
syndrome (FEPS) that is manifested by episodes of upper 
body pain, triggered by fasting and physical stress. FEPS 
patients show an enhanced cutaneous flare response with 
secondary  hyperalgesia  to  punctuate  stimuli  in  the 
presence of TRPA1 agonists [52].
TRPML1
Mucolipidosis type IV (MLIV) is caused by mutations in 
TRPML1. MLIV, an autosomal­recessive neurodegenera­
tive  lysosomal  storage  disorder  is  linked  with  psycho­
motor retardation, ophthalmologic abnormalities, failure 
of corpus callosum development, blood iron deficiency 
and  achlorhydria  [53].  TRPML1  is  a  calcium  and  iron 
permeable intracellular channel in lysosomes and, there­
fore,  possible  pathological  mechanisms  might  include 
block of the endocytotic pathway at the late endosome­
lysosome  level,  a  defect  in  autophagy  of  endocytosed 
materials and impaired iron transport [54,55].
TRPP2
Polycystic  kidney  disease  (PKD),  the  most  common 
inherited  form  of  kidney  failure,  is  associated  with  a 
mutation in TRPP2 (known also as polycystin 2). PKD is 
characterized  by  the  development  of  large  epithelial­
lined cysts that are filled with fluid and can occupy much 
of the mass of the abnormally enlarged kidneys, thereby 
compressing  and  destroying  normal  renal  tissue  and 
impairing kidney function [56].
Mechanism
The activity of TRP channels is regulated by a variety of 
mechanisms. In general, these processes require the whole 
complement of post­transcriptional modifications, includ­
ing  G­protein­coupled  receptor­related  mechanisms, 
(de)phosphorylation  and  ubiquitination.  Some  more 
general  mechanisms  of  TRP  channel  gating  and  their 
relevance to sensory modulation are discussed below.
Membrane	voltage
A significant number of TRP channels, mostly involved 
in sensory perception, have intrinsic voltage dependence 
[57­60].  The  voltage­dependent  activation  of  TRPs  is 
sensitive to other triggers, such as the presence of ligands 
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the activation by several hundreds of millivolts [59,61]. 
Similar to voltage­gated potassium channels, the mole­
cular  counterparts  involved  in  voltage  sensing  are 
probably positively charged lysine and arginine residues 
in transmembrane segment S4 and the S4­S5 linker [61]. 
For a recent review on voltage sensing and its relevance 
to the gating of TRP channels in response to thermal and 
chemical stimuli, see [62].
Membrane	phospholipids
Several studies report a direct effect of membrane phos­
pho  lipids in the regulation of TRP channel activity (for 
example, of TRPA1 and TRPV1) [63­65]. In particular, 
many TRPs are highly sensitive to phosphatidylinositol 
4,5­bisphosphate  (PtdIns(4,5)P2),  the  most  abundant 
acidic phospholipid in the plasma membrane. The plasma 
membrane  level  of  PtdIns(4,5)P2  can  change  rapidly 
because  of  the  action  of  different  PLC  isoforms  and 
phosphatidylinositol  kinases/phosphatases,  resulting  in 
modulation  of  TRP  channel  activity  [66­68].  Many 
membrane­associated  enzymes  are  also  sensitive  to 
changes in membrane PtdIns(4,5)P2 levels and, therefore, 
directly  or  indirectly  can  affect  TRP  channel  function. 
For  example,  the  membrane  protein  Pirt,  which  is 
required  for  the  stimulatory  effect  of  PtdIns(4,5)P2  on 
TRPV1  activity,  interacts  with  both  phosphoinositides 
and TRPV1 [64]. Cell­specific variations in the level of 
such regulatory proteins might explain at least some of 
the discrepancies relating to the effects of PtdIns(4,5)P2 
on the TRP channel activity [29].
Another  PtdIns(4,5)P2­related  mechanism  has  been 
proposed  for  the  cold­  and  menthol­sensitive  TRPM8 
and the Ca2+­activated taste­transducing TRPM5 channels. 
An  increased  intracellular  Ca2+  concentration  leads  to 
activation of Ca2+­dependent PLC (such as PLCδ1), result­
ing in depletion of cellular PtdIns(4,5)P2 and a subsequent 
channel decay [69,70]. This PtdIns(4,5)P2 depletion does 
not  lead  to  complete  channel  inactivation,  but  rather 
shifts the voltage dependence of channel activity to more 
positive  potentials  and  reduces  the  channel  sensitivity 
(desensitization) to ligands such as menthol (TRPM8) or 
Ca2+  (TRPM5)  [71].  Endolysosome­localized  TRPML 
channels  interact  directly  with  phosphatidylinositol 
3,5­bisphosphate, an endolysosome­specific phosphoinosi­
tide, resulting in highly specific and potent activation of 
these channels [72].
Phosphorylation
Activation  of  PLC  not  only  results  in  breakdown  of 
PtdIns(4,5)P2 but also in the activation of protein kinase 
C  (PKC).  PKC­dependent  phosphorylation  might  be  a 
direct  activatory  mechanism  or  might  sensitize  the 
channel  for  other  stimuli  (for  example,  it  sensitizes 
TRPV1  to  heat  or  capsaicin)  [73,74].  However,  PKC 
might downregulate the channel function: activation of 
PKC  initiates  the  dephosphorylation  of  TRPM8  and 
subsequent inactivation of this channel [75]. The iden­
tities  of  the  kinases  that  mediate  phosphorylation  of 
TRPM8 and the phosphorylation site in TRPM8 are still 
unknown.
An  additional  pathway  for  the  regulation  of  TRP 
channel activity following receptor stimulation is through 
protein kinase A (PKA). Activation of PKA by prosta­
glandin E2 stimulation potentiates TRPV1 responses and 
counteracts  channel  desensitization  [74].  The  PKA­
dependent modulation of TRPV1 requires anchoring of 
PKA  to  the  channel  through  the  A­kinase  anchoring 
protein  AKAP150  and  phosphorylation  of  a  single 
amino­terminal serine residue [74,76]. In TRPM8, PKA 
activation leads to desensitization of the channel activity 
by an as yet unknown mechanism. Both PKA­ and PKC­
dependent pathways have opposite effects on modulation 
of  the  heat­activated  TRPV1  and  the  cold­activated 
TRPM8 [77].
Ligands
Most  TRP  channel  activities  are  modulated  by  a  large 
number of exogenous and endogenous ligands. In parti­
cular, temperature­sensitive TRPs seem to be preferred 
targets for plant­derived chemicals. The classic example 
is heat­sensitive TRPV1, which is activated by structurally 
unrelated  botanical  compounds  such  as  capsaicin  (the 
pungent extract of hot peppers [78]), resiniferatoxin (an 
active  compound  from  the  cactus  Euphorbia  resinifera 
[79]), piperine (the pungent component in black pepper 
[80]) and camphor (the waxy substance with penetrating 
odor extracted from Cinnamomum camphora [81], which 
also  activates  TRPV3  [82]).  Other  examples  include 
TRPM8,  a  cold  receptor  directly  activated  by  menthol 
(derived  from  the  mint  plant  Mentha  piperita)  and 
eucalyptol (derived from the tree Eucalyptus globulus), 
[83,84],  and  TRPV4,  which  is  activated  by  bisandro­
grapholide (derived from the plant Andrographis panicu­
lata  [85]).  Thus,  inherent  thermal  sensation  linked  to 
application  of  certain  chemical  compounds  (chemes­
thesis) is related to activation of a single channel that can 
respond to both thermal and chemical stimuli (such as 
‘hot’ chili pepper or ‘cool’ mint).
In addition to natural plant­derived compounds, TRP 
channels respond to a wide range of synthetic ligands, 
many of which are important pharmacological tools that 
can be used to modulate channel functions. Some can 
activate  more  than  one  TRP  channel  (for  example, 
2­aminoethyl diphenylborinate activates TRPV1, TRPV2 
and  TRPV3  [86,87]  and  icilin  activates  TRPM8  and 
TRPA1 [83,88]), whereas some are relatively highly selec­
tive  for  a  particular  TRP  channel  (such  as  olvanil  for 
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lumiphorbols, phorbol­hexonates and GSK 1016790A for 
TRPV4 [90­92]).
Several  TRP  channels  are  receptors  for  endogenous 
compounds.  TRPCs  respond  to  diacyl  glycerol,  a  lipid 
product derived from PtdIns(4,5)P2 breakdown catalyzed 
by  PLC  after  a  G­protein­  or  tyrosine­kinase­coupled 
receptor­dependent  activation  [93].  Arachidonic­acid­
related  compounds  are  involved  in  gating  TRPV1 
(arachidonoyl ethanolamide, 12,15­(S)­hydroperoxy  eico­
sa  tetraenoic  acid  and  leukotriene  B4  [94])  and  TRPV4 
(5’,6’­epoxieicosatrienoic  acid  [95]),  and  sphingosine,  a 
primary  part  of  sphingolipids,  activates  TRPM3  [96]. 
However, the mechanisms of these gating behaviors of 
TRP channels are currently unknown.
Frontiers
The  discovery  of  TRP  channels  has  revolutionized  our 
understanding of many sensory and general physiological 
processes. TRPs generally act in concert with other ion 
channels and proteins. Given that, in many cases, these 
mechanisms are evolutionarily conserved from inverte­
brates  to  humans,  it  is  not  surprising  that  inherited 
impairments of TRP channel functions lead to disease. In 
addition, changes in channel expression levels or channel 
sensitization or desensitization, resulting in exaggerated 
or diminished responses to various pathological stimuli, 
can  also  contribute  to  pathophysiology  of  TRP­related 
diseases.  Various  endogenous  agents  released  during 
early  disease  stages  can  also  influence  TRP  channel 
functions and lead to inflammation and the progression 
of the disease (for example, release of leukotriene B4 leads 
to  TRPV1  activation).  These  findings  highlight  TRP 
channels as important pharmacological targets. Several 
TRPV1 antagonists function as analgesic agents for the 
treatment of chronic pathological pain [97]. The classic 
natural  pungent  TRPV1  agonist,  capsaicin,  has  been 
reported as a possible relief agent for some patients with 
tonic  neuropathic  pain  [98].  Several  lines  of  evidence 
suggest that blocking TRPC6 function might be clinically 
beneficial  for  FSGS  patients  [99].  Preliminary  results 
demonstrate  that  the  commonly  used  immuno  sup­
pressive agent FK­506 can inhibit TRPC6 activity in vivo 
and might be a possible treatment for idiopathic FSGS 
[100]. Another example is a small molecule antagonist of 
TRPV4,  HC­067047,  which  may  provide  promising 
means  for  the  treatment  of  bladder  dysfunction  [101]. 
Therefore,  further  understanding  of  the  (patho)
physiological roles and activation mechanisms of these 
channels may provide novel insights into the etiology and 
possible treatments of many TRP­related diseases.
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